Market Capitalization of Brooks Laboratories (BROOKS)
As of Sept. 18, 2026, Brooks Laboratories (BROOKS) market capitalisation is ₹193.50 Cr ($21.50M), with 3.14 Cr shares outstanding at a current price of ₹61.53 on NSE, ranking 2603 out of 5367 companies by market cap in our screener. Brooks Laboratories operates in the Healthcare sector and is classified as a Small Cap stock. View BROOKS price range for the annual high/low range and current price position.
Market Cap History of Brooks Laboratories (Last 10 Years)
BROOKS market capitalisation from year-end NSE closing prices over the last 10 years. For live price, earnings and the complete company profile, see Brooks Laboratories screener.
End of Year Market Cap History — Brooks Laboratories
BROOKS year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. Explore BROOKS intrinsic value to estimate fundamental worth using multiple valuation models.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹193.50 Cr
$21.50M USD
|
₹61.53 | NSE | -23.22% |
| 2025 |
₹252.02 Cr
$28.00M USD
|
₹80.14 | NSE | -56.67% |
| 2024 |
₹581.63 Cr
$64.63M USD
|
₹184.95 | BSE | +28.39% |
| 2023 |
₹453.01 Cr
$50.33M USD
|
₹144.05 | BSE | +33.02% |
| 2022 |
₹340.55 Cr
$37.84M USD
|
₹108.29 | BSE | +9.57% |
| 2021 |
₹310.80 Cr
$34.53M USD
|
₹98.83 | BSE | +50.17% |
| 2020 |
₹206.96 Cr
$23.00M USD
|
₹65.81 | BSE | +128.35% |
| 2019 |
₹90.63 Cr
$10.07M USD
|
₹28.82 | BSE | -51.85% |
| 2018 |
₹188.25 Cr
$20.92M USD
|
₹59.86 | BSE | -46.89% |
| 2017 |
₹354.42 Cr
$39.38M USD
|
₹112.70 | BSE | -14.94% |
| 2016 |
₹416.69 Cr
$46.30M USD
|
₹132.50 | BSE | +45.03% |
| 2015 |
₹287.31 Cr
$31.92M USD
|
₹91.36 | BSE | +105.26% |
| 2014 |
₹139.98 Cr
$15.55M USD
|
₹44.51 | BSE | +125.25% |
| 2013 |
₹62.14 Cr
$6.90M USD
|
₹19.76 | BSE | -10.10% |
| 2012 |
₹69.12 Cr
$7.68M USD
|
₹21.98 | BSE | +73.34% |
| 2011 |
₹39.88 Cr
$4.43M USD
|
₹12.68 | BSE | - |